Vetigenics is focused on advancing targeted antibody-based therapies for pets with cancer and other chronic diseases. The company aims to transform personalized healthcare for pets while supporting advancements in human medicine, based on its proprietary CANIBODY™ platform.

Vetigenics

Corbiota develops natural animal health and welfare solutions that aim to improve productivity while meeting farmers' requirements. This is self-described as creating a new standard in animal nutrition.

Corbiota

HealthforAnimals represents the animal health sector: manufacturers of veterinary pharmaceuticals, vaccines and other animal health products throughout the world, as well as the associations that represent companies at national and regional levels.

Metric
Company Name	Vetigenics	Corbiota	HealthforAnimals
Symbol
MSH ID	COM:VETIGENICS	COM:CORBIOTA	ORG:HEALTHFORANIMALS
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Consumer Goods	Healthcare & Health Services
Industry	Biotechnology	Animal Nutrition	Animal Health
Country	US	DE	BE
Stage
Employee Count
Website	vetigenics.com	corbiota.com	healthforanimals.org
LinkedIn
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic			8.89K
Web Traffic Growth			0.68
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:VETIGENICS

Vetigenics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue